Funder
Coley Pharmaceutical Group, Inc.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Immunology,Immunology and Allergy
Reference53 articles.
1. Yagoda A, Bander NH (1989) Failure of cytotoxic chemotherapy, 1983–1988, and the emerging role of monoclonal antibodies for renal cancer. Urol Int 44:338–345.
https://doi.org/10.1159/000281537
2. Coppin C, Porzsolt F, Autenrieth M et al (2004) Immunotherapy for advanced renal cell cancer. In: Coppin C (ed) Cochrane database of systematic reviews. Wiley, Chichester, p CD001425
3. Rodriguez-Vida A, Hutson TE, Bellmunt J, Strijbos MH (2017) New treatment options for metastatic renal cell carcinoma. ESMO Open 2:e000185.
https://doi.org/10.1136/esmoopen-2017-000185
4. Motzer RJ, Tannir NM, McDermott DF et al (2018) Nivolumab plus Ipilimumab versus sunitinib in advanced renal-cell carcinoma. N Engl J Med 378:1277–1290.
https://doi.org/10.1056/NEJMoa1712126
5. Schumacher TN, Schreiber RD (2015) Neoantigens in cancer immunotherapy. Science 348:69–74.
https://doi.org/10.1126/science.aaa4971
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献